ebola

SAB immunotherapy neutralizes Ebola in animal study

Sioux Falls-based SAB Biotherapeutics used its anti-Ebola immunotherapy to provide 100 percent protection against a lethal dose of the disease in a recent animal study.

2 years ago

News Tip

Have a business news item to share with us?

Scroll to top